Journal
CELL STEM CELL
Volume 6, Issue 6, Pages 591-602Publisher
CELL PRESS
DOI: 10.1016/j.stem.2010.03.016
Keywords
-
Categories
Funding
- National Defense Science and Engineering
- NIDDK [K08DK080175]
- Burroughs Wellcome Fund
- Howard Hughes Medical Institute
- MGH
- Croucher Foundation
- National Cancer Institute [R37CA058596, P50CA101942]
- National Human Genome Research Institute
Ask authors/readers for more resources
Wilms tumor is the most common pediatric kidney cancer. To identify transcriptional and epigenetic mechanisms that drive this disease, we compared genome-wide chromatin profiles of Wilms tumors, embryonic stem cells (ESCs), and normal kidney. Wilms tumors prominently exhibit large active chromatin domains previously observed in ESCs. In the cancer, these domains frequently correspond to genes that are critical for kidney development and expressed in the renal stem cell compartment. Wilms cells also express embryonic chromatin regulators and maintain stem cell-like p16 silencing. Finally, Wilms and ESCs both exhibit bivalent chromatin modifications at silent promoters that may be poised for activation. In Wilms tumor, bivalent promoters correlate to genes expressed in specific kidney compartments and point to a kidney-specific differentiation program arrested at an early-progenitor stage. We suggest that Wilms cells share a transcriptional and epigenetic landscape with a normal renal stem cell, which is inherently susceptible to transformation and may represent a cell of origin for this disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available